Inventing future therapies. Now.
THE BERLIN CENTER FOR GENE AND CELL THERAPIES IS WHERE START-UPS COME TO TRANSLATE GENE AND CELL THERAPY RESEARCH INTO A POSITIVE PATIENT IMPACT.
This center is a unique combination of research, manufacturing, and consulting – enabling start-ups to transform research into market-ready therapy with comprehensive support, access to expertise, labs, and manufacturing facilities.
For the benefit of patients.
Gene and cell therapies (GCTs) have the potential to transform the lives of patients and revolutionize the way we manage diseases and healthcare. They are highly innovative therapies that aim to prevent, stop, or reverse disease progression by addressing its root cause – and to make the treatment of presently untreatable diseases possible.
Going beyond. Together.
The Berlin Center for Gene and Cell Therapies, jointly initiated by Bayer and Charité, will be a unique hub within an inspiring biotech ecosystem. It combines a cutting-edge incubator with state-of-the-art laboratories and GMP manufacturing facilities, offices and communal spaces, as well as specialized mentoring programs to support every phase - from research to realization.
The incubator area
The incubator is the heart of the hub, fully equipped with everything start-ups need, from ready-to-use labs and modern offices, to joint working areas and conference rooms. Spanning a large 5,000 square meters, this is the ideal environment to thrive. Custom service agreements are available for lab benches and desks, which are vital for the preclinical stage.
The manufacturing plant
ProBioGen will operate the Good Manufacturing Practice (GMP) - Manufacturing unit commissioned by the Berlin Institute of Health (BIH).
With a view towards the clinical trial stage, start-ups have the opportunity from the very start to interact closely with experts from the GMP facility and smoothly transfer their pre-GMP process development to larger scales. Tenants of the incubator get preferential access to the seven production rooms, totaling 4.600 square meters.
Mentoring and consulting services.
Knowledge increases by sharing. This can’t be more true than for our open network with experts and mentors for all relevant fields start-ups aiming to make a difference in GCT: from entrepreneurship and business development, to regulatory affairs, clinical development, and more.
The place for innovators.
The center is located in the heart of Berlin, just a ten-minute bike ride from Berlin central station and overlooking the waters of Nordhafen. Neighbouring the Bayer campus it is located between the two Charité campuses and close to the Berlin Institute of Health (BIH), surrounded by other world-renowned institutions like the MDC. Distances are short to the rich pool of skilled professionals and scientists, enabling the circulation and cross-fertilization of ideas.
Furthermore, co-located in the same building will be Bayer Co.Lab Berlin strengthening the biotech ecosystem.
Our partners.
The future has started.
Together with Germany’s Federal Chancellor Olaf Scholz and high-caliber government officials, Bayer and Charité publicly launched the Berlin Center for Gene and Cell Therapies in June 2024 – setting the start for this future powerhouse of GCT innovation.